Lista de obras -

A polygenic risk score for multiple myeloma risk prediction

artículo científico publicado en 2022

ABCC3 and GSTM5 gene polymorphisms affect overall survival in Polish acute myeloid leukaemia patients

artículo científico publicado en 2021

Acquired thrombotic thrombocytopenic purpura (TTP) induced by silicone breast implants in 37-year old woman

artículo científico publicado en 2013

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

artículo científico publicado en 2017

Association of RANK and RANKL gene polymorphism with survival and calcium levels in multiple myeloma

artículo científico publicado en 2020

Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study

artículo científico publicado en 2018

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

artículo científico publicado en 2017

Azacitidine in outpatient treatment - single center experience.

artículo científico publicado en 2016

BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia

artículo científico publicado en 2022

BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients.

artículo científico publicado en 2018

Bendamustine as monotherapy and in combination regimens for the treatment of chronic lymphocytic leukemia and non-hodgkin lymphoma: a retrospective analysis

artículo científico publicado en 2013

Bone marrow iron depletion is common in patients with coronary artery disease

artículo científico publicado en 2014

Breast cancer and synchronous multiple myeloma as a diagnostic challenge: Case report and review of literature.

artículo científico publicado en 2017

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

artículo científico publicado en 2016

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium

scientific article published on 20 November 2019

Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma.

scientific article published on 12 January 2017

Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients.

artículo científico publicado en 2016

Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival

scientific article published on 05 November 2020

Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factor

artículo científico publicado en 2014

Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?

artículo científico publicado en 2020

Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.

artículo científico publicado en 2016

Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients--Report of the Polish Myeloma Group

artículo científico publicado en 2015

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

artículo científico publicado en 2019

Expression of bone morphogenetic proteins (BMPs) receptors in patients with B-cell chronic lymphocytic leukemia (B-CLL).

artículo científico publicado en 2010

Expression of cyclin A and bone morphogenetic protein receptors and response to induction therapy in patients with acute leukemias

artículo científico publicado en 2011

Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemia

scientific article published on 08 August 2016

Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients.

artículo científico publicado en 2015

Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

artículo científico publicado en 2021

First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.

artículo científico publicado en 2019

G-CSF administration favours SDF-1 release and activation of neutrophils and monocytes in recipients of autologous peripheral blood progenitor cells

scientific article published on 24 January 2019

Gemcitabine-Based Treatment in Poor-Prognosis Patients with Relapsed and Refractory Hodgkin Lymphoma and Non-Hodgkin Lymphoma--a Multicenter Polish Experience

artículo científico publicado en 2015

Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms

artículo científico publicado en 2020

Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

article

Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia

artículo científico publicado en 2018

Genetically determined telomere length and multiple myeloma risk and outcome

artículo científico publicado en 2021

HIGH SOLUBLE TRANSFERRIN RECEPTOR IN PATIENTS WITH SYSTOLIC HEART FAILURE: A MEASURE OF IRON DEFICIENCY AND A STRONG PREDICTOR OF MORTALITY

High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients.

artículo científico publicado en 2013

High Soluble Transferrin Receptor in Patients With Heart Failure: a Measure of Iron Deficiency And a Strong Predictor of Mortality

artículo científico publicado en 2020

High expression of CC chemokine receptor 5 (CCR5) promotes disease progression in patients with B-cell non-Hodgkin lymphomas.

artículo científico publicado en 2018

High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients

artículo científico publicado en 2012

Identification of miRSNPs associated with the risk of multiple myeloma.

artículo científico publicado en 2016

Inability to exist independently in the course of breast cancer-main risk factors

artículo científico publicado en 2021

Increased monocyte chemoattractant protein 1 (MCP-1/CCL-2) serum level in acute myeloid leukemia

scientific article published on 01 January 2007

Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients

artículo científico publicado en 2018

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

artículo científico publicado en 2015

Iron Dysregulation and Frailty Syndrome

artículo científico publicado en 2021

Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients.

artículo científico publicado en 2015

Plasma fatty acid profile in multiple myeloma patients.

artículo científico publicado en 2014

Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q).

artículo científico publicado en 2015

Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment.

artículo científico publicado en 2015

Prevalence and clinical presentation of lymphoproliferative disorder in patients with primary Sjögren's syndrome

scientific article published on 01 February 2020

Programmed cell death protein receptor and ligands in haematological malignancies - Current status

scientific article published on 25 January 2019

Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin's lymphoma

artículo científico publicado en 2011

Quality of life in children with acute lymphoblastic leukaemia

scientific article published on 23 July 2019

Serum NMR metabolomics to differentiate haematologic malignancies

artículo científico publicado en 2018

Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma

artículo científico publicado en 2022

Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma

artículo científico publicado en 2022

Subcutaneous panniculitis-like T-cell lymphoma in type 1 neurofibromatosis: a case report

artículo científico publicado en 2014

Systemic Lupus Erythematosus Induced by Autoimmune/ Inflammatory Syndrome Induced by Adjuvants. Is it Possible? Long-Term Follow-up and Literature Review

artículo científico publicado en 2018

TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia

artículo científico publicado en 2021

The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma.

artículo científico publicado en 2013

The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.

artículo científico publicado en 2016

The expression of Toll-like receptors and development of severe sepsis in patients with acute myeloid leukemias after induction chemotherapy

artículo científico publicado en 2014

The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy.

artículo científico publicado en 2015

Unclassifiable small B-cell lymphoma with marked plasmacytic differentiation and Mott cell formation.

artículo científico publicado en 2013

[New trends in non-Hodgkin's lymphoma therapy]

scientific article published on 01 January 2006

bFGF Polymorphism Is Associated with Disease Progression and Response to Chemotherapy in Multiple Myeloma Patients.

artículo científico publicado en 2017

Lista de obras de

A polygenic risk score for multiple myeloma risk prediction

ABCC3 and GSTM5 gene polymorphisms affect overall survival in Polish acute myeloid leukaemia patients

Acquired thrombotic thrombocytopenic purpura (TTP) induced by silicone breast implants in 37-year old woman

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

Association of RANK and RANKL gene polymorphism with survival and calcium levels in multiple myeloma

Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

Azacitidine in outpatient treatment - single center experience.

BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia

BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients.

Bendamustine as monotherapy and in combination regimens for the treatment of chronic lymphocytic leukemia and non-hodgkin lymphoma: a retrospective analysis

Bone marrow iron depletion is common in patients with coronary artery disease

Breast cancer and synchronous multiple myeloma as a diagnostic challenge: Case report and review of literature.

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium

Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma.

Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients.

Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival

Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factor

Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?

Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.

Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients--Report of the Polish Myeloma Group

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Expression of bone morphogenetic proteins (BMPs) receptors in patients with B-cell chronic lymphocytic leukemia (B-CLL).

Expression of cyclin A and bone morphogenetic protein receptors and response to induction therapy in patients with acute leukemias

Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemia

Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients.

Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.

G-CSF administration favours SDF-1 release and activation of neutrophils and monocytes in recipients of autologous peripheral blood progenitor cells

Gemcitabine-Based Treatment in Poor-Prognosis Patients with Relapsed and Refractory Hodgkin Lymphoma and Non-Hodgkin Lymphoma--a Multicenter Polish Experience

Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms

Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia

Genetically determined telomere length and multiple myeloma risk and outcome

HIGH SOLUBLE TRANSFERRIN RECEPTOR IN PATIENTS WITH SYSTOLIC HEART FAILURE: A MEASURE OF IRON DEFICIENCY AND A STRONG PREDICTOR OF MORTALITY

High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients.

High Soluble Transferrin Receptor in Patients With Heart Failure: a Measure of Iron Deficiency And a Strong Predictor of Mortality

High expression of CC chemokine receptor 5 (CCR5) promotes disease progression in patients with B-cell non-Hodgkin lymphomas.

High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients

Identification of miRSNPs associated with the risk of multiple myeloma.

Inability to exist independently in the course of breast cancer-main risk factors

Increased monocyte chemoattractant protein 1 (MCP-1/CCL-2) serum level in acute myeloid leukemia

Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Iron Dysregulation and Frailty Syndrome

Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients.

Plasma fatty acid profile in multiple myeloma patients.

Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q).

Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment.

Prevalence and clinical presentation of lymphoproliferative disorder in patients with primary Sjögren's syndrome

Programmed cell death protein receptor and ligands in haematological malignancies - Current status

Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin's lymphoma

Quality of life in children with acute lymphoblastic leukaemia

Serum NMR metabolomics to differentiate haematologic malignancies

Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma

Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma

Subcutaneous panniculitis-like T-cell lymphoma in type 1 neurofibromatosis: a case report

Systemic Lupus Erythematosus Induced by Autoimmune/ Inflammatory Syndrome Induced by Adjuvants. Is it Possible? Long-Term Follow-up and Literature Review

TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia

The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma.

The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.

The expression of Toll-like receptors and development of severe sepsis in patients with acute myeloid leukemias after induction chemotherapy

The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy.

Unclassifiable small B-cell lymphoma with marked plasmacytic differentiation and Mott cell formation.

[New trends in non-Hodgkin's lymphoma therapy]

bFGF Polymorphism Is Associated with Disease Progression and Response to Chemotherapy in Multiple Myeloma Patients.